Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Ralph Weichselbaum
University of Chicago, Department: Genetics
Should you be removed from our database? Contact us at [email protected]. Read more below.
Onosenescence
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Weichselbaum has been involved in developing oncolytic herpes simplex viruses (oHSV). He has also been involved in developing radiation therapy systems for cancer treatment. Onosenescence is a start up company that screens for drugs that induce tumor cell senescence and senescent tumor cell vaccines. There is on-going work in his lab related to this company. The University has evaluated the work, and believes a potential conflict of interest might exist with the study "Radiation within the tumor microenvironment".
Radiation response within the tumor microenvironment
Narrative Radiation therapy is a widely used treatment for cancer, but cures a minority of patients. One hypothesis is that inadequate blood flow in tumors protects some cells from radiation. This project will use advanced imaging methods to examine how radiation affects cancer cells in experimental tumors, and how this relates to blood flow. We will then apply systems biology approaches to begin to model how cancer cells survive radiation and how we might achieve better results.
Filed on February 12, 2013.
Tell us what you know about Ralph Weichselbaum's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Ralph Weichselbaum”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Ralph Weichselbaum | University of Chicago | Conflict of Interest | RefleXion Medical | Value cannot be readily determined |
| Ralph Weichselbaum | University of Chicago | Conflict of Interest | Coordination Pharmaceuticals, Inc. | Value cannot be readily determined |
| Ralph Weichselbaum | University of Chicago | Conflict of Interest | RefleXion Medical | Value cannot be readily determined |
| Ralph Weichselbaum | University of Chicago | Conflict of Interest | RefleXion Medical | Value cannot be readily determined |
| Ralph Weichselbaum | University of Chicago | Conflict of Interest | Onosenescence | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.